Full name: Maxime Breban
Current country: France
Membership level: Full
Type of membership: Member
Number of publications: 23
Lessons on SpA pathogenesis from animal models (2021)
https://doi.org/10.1007/s00281-020-00832-x
Cluster analysis in early axial spondyloarthritis predicts poor outcome in the presence of peripheral articular manifestations (2021)
https://doi.org/10.1093/rheumatology/keab873
Randomized Cross Over Study Assessing the Efficacy of Non-invasive Stimulation of the Vagus Nerve in Patients With Axial Spondyloarthritis Resistant to Biotherapies: The ESNV-SPA Study Protocol (2021)
https://doi.org/10.3389/fnhum.2021.679775
Rodent Models of Spondyloarthritis Have Decreased White and Bone Marrow Adipose Tissue Depots (2021)
https://doi.org/10.3389/fimmu.2021.665208
What Have We Learned From Family-Based Studies About Spondyloarthritis? (2021)
https://doi.org/10.3389/fgene.2021.671306
Axial spondyloarthritis: emerging drug targets (2021)
https://doi.org/10.1080/14728222.2021.1973429
Intestinal dysbiosis in spondyloarthritis – chicken or egg? (2021)
https://linkinghub.elsevier.com/retrieve/pii/S1521694220300127
Monocyte transcriptomes from patients with axial spondyloarthritis reveal dysregulated monocytopoiesis and a distinct inflammatory imprint (2021)
https://doi.org/10.1186/s13075-021-02623-7
Effects of a low-dose IL-2 treatment in HLAB27 transgenic rat model of spondyloarthritis (2021)
https://doi.org/10.1186/s13075-021-02559-y
Epigenetics of spondyloarthritis (2020)
https://doi.org/10.1016/j.jbspin.2020.06.003
Genomewide Association Study of Acute Anterior Uveitis Identifies New Susceptibility Loci (2020)
https://doi.org/10.1167/iovs.61.6.3
Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis (2020)
https://ard.bmj.com/content/80/9/1168
HLA–B27 Subtypes Predisposing to Ankylosing Spondylitis Accumulate in an Endoplasmic Reticulum–Derived Compartment Apart From the Peptide-Loading Complex (2020)
https://doi-org/10.1002/art.41281
Editorial: Ankylosing Spondylitis and Related Immune-Mediated Disorders (2019)
https://doi.org/10.3389/fimmu.2019.01232
The microbiome in spondyloarthritis (2019)
https://doi.org/10.1016/j.berh.2020.101495
Tolerogenic XCR1+ dendritic cell population is dysregulated in HLA-B27 transgenic rat model of spondyloarthritis (2019)
https://doi.org/10.1186/s13075-019-1827-9
HLA-B27 alters BMP/TGFβ signalling in Drosophila, revealing putative pathogenic mechanism for spondyloarthritis (2019)
https://ard.bmj.com/content/78/12/1653
Burden ofseverespondyloarthritisinFrance:Anationwide assessment ofprevalence,associatedcomorbiditiesandcost (2018)
https://doi.org/10.1016/j.jbspin.2018.04.003
Abrupt and unexpected stressful life events are followed with increased disease activity in spondyloarthritis: a two years web-based cohort study (2018)
https://doi.org/doi:10.1016/j.jbspin.2018.05.009
Genetics and Functional Genomics of Spondyloarthritis (2018)
https://doi.org/10.3389/fimmu.2018.02933
Radiographic sacroiliitis develops predictably over time in a cohort of familial spondyloarthritis followed longitudinally (2017)
https://academic.oup.com/rheumatology/article-lookup/doi/10.1093/rheumatology/kew496
Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis (2017)
https://doi.org/10.1186/s13059-017-1271-6
Faecal microbiota study reveals specific dysbiosis in spondyloarthritis (2017)
https://ard.bmj.com/content/76/9/1614